Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -20.554% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: COc1cc(O)c(C(CCN2CCCC2)c2cc(OC)c(OC)c(OC)c2)c(OC)c1
b: Cc1nn(CCC(=O)NNC(=S)Nc2ccc([N+](=O)[O-])cc2)c(C)c1[N+](=O)[O-]
c: O=C1CN(C(=O)CSc2nc3ccccc3n2CCc2ccccc2)c2ccccc2N1
d: CCN(CCn1cccn1)C(=O)CCc1nnc(-c2ccccc2)o1
Answer: c. O=C1CN(C(=O)CSc2nc3ccccc3n2CCc2ccccc2)c2ccccc2N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1CN(C(=O)CSc2nc3ccccc3n2CCc2ccccc2)c2ccccc2N1
O=C1CN(C(=O)CSc2nc3ccccc3n2CCc2ccccc2)c2ccccc2N1
4-[2-[1-(2-phenylethyl)benzimidazol-2-yl]sulfanylacetyl]-1,3-dihydroquinoxalin-2-one